Jeannine A. Villella DO FACOG, FACS
Gynecologic Oncology
Director, northwell Health Cancer Institute Manhattan Vice President, Northwell Health OBGYN Western Region Vice Chair, Gynecology; Chief, Gynecologic Oncology Lenox Hill Hospital/ Northwell Health Associate Professor Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell Health
Join to view full profile
111 East 57th Street3rd FloorNew York, NY 10022
Phone+1 212-434-3770
Fax+1 212-434-3775
Dr. Villella is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University at BuffaloFellowship, Gynecologic Oncology, 2003 - 2006
NYU Grossman Long Island School of MedicineResidency, Obstetrics and Gynecology, 1997 - 2001
NYIT College Of Osteopathic MedicineClass of 1997
Certifications & Licensure
NY State License 2000 - 2027
NJ State License 2001 - 2003
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2015-2016
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2015-2016
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Collecting Tumor Samples From Patients With Gynecological Tumors
Publications & Presentations
PubMed
- Pituitary Metastasis as the Initial Manifestation of an Undiagnosed Adenocarcinoma of Mullerian Origin: A Case Report and Literature Review.Aruuke Sulaimanova, Brianna Suffren, Iuliia Lakhina, Puneet S Pawha, John A Boockvar
International Journal of Surgical Pathology. 2026-08-01 - Expanded subtype testing for circulating tumor HPV DNA reliably detects the presence of advanced-stage cervical cancer.Kersten Rothnie, Emilie Tristano, Mariuxi Diaz-Rodriguez, Olga Filippova, Gizelka David-West
Gynecologic Oncology. 2026-04-01 - Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic ...Vinita Popat, Paul H Frankel, Nora H Ruel, Susan E Yost, Sue Chang
Pleura and Peritoneum. 2026-03-01
Press Mentions
Oncologist to Lead Northwell Health Cancer InstituteOctober 18th, 2022- Woman Details Having 'Watermelon'-Sized Ovarian Cyst RemovedJuly 20th, 2021
Endometrial Cancer: A Society of Gynecologic Oncology Evidence-Based Review and RecommendationsJanuary 27th, 2021
Professional Memberships
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
